-0.02 | -0.43%
| Price and Volume | |
|---|---|
| Recent Price | 4.61 |
| 52 Week High | 6.02 |
| 52 Week Low | 4.00 |
| Avg. Daily Vol. (Mil) | 0.08 |
| Beta (3 year) | 0.77 |
| Share Related Items | |
| Mkt Cap (Mil) | 127.03 |
| Shares Out (Mil) | 27.55 |
| Float (Mil) | 25.40 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.90 |
| Current Ratio | 4.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 19.20 |
| Price/Sales | 1.19 |
| Price/Book | 1.04 |
| Price/Cash Flow | 10.60 |
| Per Share Data | |
| Earnings | 0.24 |
| Sales | 3.89 |
| Book Value | 4.42 |
| Cash Flow | 0.44 |
| Business Summary | |
|---|---|
| CryoLife, Inc. preserves and distributes human tissues; develops, manufactures and commercializes medical devices for cardiac and vascular transplant applications. | |
| General Information | |
| 1655 Roberts Boulevard
North West Kennesaw, GA 30144 |
|
| www.cryolife.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 430 | |
| CEO: Steven G. Anderson | |
| Short Interest | |
| Current Month (Mil) | 0.75 |
| Previous Month (Mil) | 0.71 |
| Short Interest Ratio (Days) | 11.70 |
| Management Effectiveness | |
| Return on Equity | 5.50 |
| Return on Assets | 4.50 |
| Return on Investments | 5.50 |
| Profitability | |
| Gross Margin | 64.70 |
| EBIT Margin | 10.00 |
| Profit Margin | 6.20 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet